Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.
The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov .
Updates regarding government operating status and resumption of normal operations can be found at OPM.gov .

Dr. Dmitri Gnatenko

Dr. Dmitri Gnatenko

Scientific Review Officer



Biography

Division:
Division of Translational and Clinical Sciences – DTCS
Review Branch:
Integrative Vascular Biology and Hematology – IVBH
Study Section:
Small Business: Cardiovascular Sciences Activities SEP – IVBH (11)

Dr. Dmitri Gnatenko holds a Ph.D. degree in molecular biology from the Institute of Molecular Biology and Genetics of the National Academy of Sciences of Ukraine. His postdoctoral studies at the Division of Hematology of Stony Brook University’s School of Medicine focused on gene therapy approaches for hemophilia A utilizing recombinant adeno-associated virus and resulted in a U.S. Patent. Prior to joining CSR, Dr. Gnatenko served as a faculty member and the Director of the Genomics Core Facility at Stony Brook University. His research expertise includes molecular mechanisms of thrombocytosis, as well as gene expression profiling and epigenetic regulation in hepatocellular carcinoma. Dr. Gnatenko pioneered research in the field of platelet transcriptome by providing a first panoramic overview of mRNAs expressed in human platelets. Dr. Gnatenko reviewed grant applications for NIH and the Wellcome Trust (UK) he also taught graduate level courses in bioinformatics.

 

Last updated: 08/22/2025 05:01